HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

11th Edition of World Congress on Infectious Diseases

June 28-30, 2027 | Rome, Italy

June 28 -30, 2027 | Rome, Italy
Infection 2024

Factors associated with non-adherence to tuberculosis (TB) preventive treatment among adult contacts of pulmonary TB cases with latent TB infection in Spain

Speaker at Infectious Diseases Conferences - Pedro Plans Rubio
College of Physicians of Barcelona, Spain
Title : Factors associated with non-adherence to tuberculosis (TB) preventive treatment among adult contacts of pulmonary TB cases with latent TB infection in Spain

Abstract:

The aim of this study was to identify factors associated with non-adherence to tuberculosis (TB) preventive treatment among contacts with latent TB infection for new cases of pulmonary TB cases reported in Catalonia in 2019–2021. All contacts aged 18 years or older with a latent TB infection who received a TB preventive treatment were included in the study. Multiple logistic regression analysis was used to detect the independent factors associated with TB preventive treatment non-adherence; a p < 0.05 was considered statistically significant. The percentage of non-adherence to TB preventive treatment found in this study was 23.7%. A multivariable logistic regression analysis determined that the following factors were significantly associated with TB preventive treatment non-adherence among adult contacts: “exposure at school or workplace” (aOR = 3.34), “exposure to an index case without laboratory confirmation of TB” (aOR = 2.07), “immigrant contact” (aOR = 1.81), “male gender” (aOR = 1.75) and “exposure duration < 6 h per week or sporadic” (aOR = 1.60. By contrast, the factor “short-term TB preventive treatment regimen” (aOR = 0.38) was significantly associated with a lower treatment non-adherence. Adherence to TB preventive treatment should be improved among adult contacts of TB pulmonary cases with latent TB infection by recommending short-term treatment regimens and by developing health education activities, with a greater focus on contacts with factors associated with treatment non-adherence.

Biography:

Pedro Plans-Rubió is member of the College of Physicians of Barcelona, Spain. MD, PhD, MSc in Health Economics, and MSc in Research Methods. Responsible for Health Registries at the Public Health Agency, Department of Health of Catalonia, Spain, until 2025. Specialized in Preventive Medicine and Public Health. Specialized in Labor Medicine. Expert of the European Commission for assessing public health and health economics projects. Member of the Group of Prioritization of Treatments (GIP), Heath Emergency Preparedness and Response (HERA), European Commission. Member of the non-communicable diseases risk factor Collaboration (NCD-RisC) research group. Member of the CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain (until 2025). Editor-in Chief of Section “Vaccine Advancement, Efficacy and Safety” of the journal Vaccines. Editor of the journal Pharmacoeconomics Open. Associate Editor of Section "Cancer Immunity and Immunotherapy" of the journal Frontiers in Immunology and the journal Frontiers in Oncology. Dr. Plans-Rubió has developed and participated in epidemiological and seroepidemiologic studies of measles, mumps, rubella, pertussis, tetanus, diphtheria, polio, hepatitis A, hepatitis B, hepatitis C, tuberculosis, SARS-CoV-2 and influenza. He has authored and co-authored peer-reviewed publications on the evaluation of vaccines and vaccination programs, the epidemiology of infectious diseases, the epidemiology of factors associated with chronic diseases, the economic evaluation of drugs, and the strategies of prevention and control of vaccine-preventable diseases. Dr. Plans-Rubió is author of the book “Application of the cost-effectiveness of medicines and health programs in the health planning” (Elsevier).

Watsapp